Company Performance - Walgreens Boots Alliance (WBA) shares closed at $9.70, reflecting a -0.51% change from the previous trading day, underperforming the S&P 500's daily loss of 0.01% [1] - Over the past month, WBA shares have depreciated by 24.59%, significantly lagging behind the Retail-Wholesale sector's gain of 9.64% and the S&P 500's gain of 4.88% [1] Upcoming Earnings - The upcoming earnings release is anticipated, with an expected EPS of $0.53, indicating a 55.83% decrease from the same quarter last year [2] - Quarterly revenue is forecasted at $38.07 billion, representing a 2.75% increase from the previous year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $1.60 per share, a decline of 44.44% from the prior year, while revenue is expected to reach $151.57 billion, reflecting a 2.65% increase [3] Analyst Estimates - Recent changes to analyst estimates suggest a shift in short-term business patterns, with positive revisions indicating optimism about the company's outlook [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks WBA as 3 (Hold) [6] Valuation Metrics - WBA is trading with a Forward P/E ratio of 6.09, which is higher than the industry average of 4.58 [7] - The company has a PEG ratio of 1.22, compared to the industry average PEG ratio of 0.7, indicating a premium valuation [8] Industry Context - The Retail - Pharmacies and Drug Stores industry is part of the Retail-Wholesale sector and holds a Zacks Industry Rank of 89, placing it in the top 36% of over 250 industries [8][9] - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [9]

NEW YORK, Feb. 14, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/walgreens-boots-a ...

Walgreens Boots Alliance has hired a firm to sell its stake in doctor-staffed clinic operator ... [+] VillageMD, which has already cost the drugstore giant billions of dollars.Walgreens Boots Alliance Walgreens Boots Alliance is getting closer to selling its stake in doctor-staffed clinic operator VillageMD, which has already cost the drugstore giant billions of dollars.Walgreens is working with the investment banking firm Evercore and the consulting firm Alvarez & Marsal as advisors in the sale, several ne ...

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Walgreens Boots Alliance, Inc. (NASDAQ: WBA).Shareholders who purchased shares of WBA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/walgreens-boots-alliance-inc-loss-submission-form-2/?id=128954&from=4 CLASS ...

Walgreens Boots Alliance-backed healthcare clinic chain VillageMD is reportedly working with advisers to explore a sale, restructuring or other options.This move comes after Walgreens CEO Tim Wentworth said during a January earnings call that the company plans to divest VillageMD, Bloomberg reported Wednesday (Feb. 12).A Walgreens spokesperson told Bloomberg that Walgreens “is continuing to work toward executing its stated goal of securing an endpoint for its investment in VillageMD, consistent with Walgree ...

Walgreens is set to close five locations across Los Angeles and Orange counties in the coming weeks — a move that could result in at least 93 job losses as the struggling retailer moves ahead with a downsizing that will see around 1,200 closures nationwide.The pharmacy chain will shutter stores in Whittier, downtown Los Angeles, Orange, Placentia and Stanton, according to a notice submitted to California’s Employment Development Department.The store closures will lead to layoffs for a range of employees, in ...

Walgreens Boots Alliance (WBA -6.12%) faces an uncertain path ahead. Its financials haven't been strong in recent years, and its struggling pharmaceutical operations face growing competition. While it is slashing its store count, there's no surefire strategy that will turn the business around.Shares of the pharmacy retailer haven't been this low in decades. And while some investors may have been willing to just hang on to the stock amid the uncertainty and simply collect its dividend, now, even that is gone ...

I last analyzed Walgreens Boots Alliance (NASDAQ: WBA ) on 10-29-2024. In an article entitled "Walgreens Q4: 2 Signs Of A Dividend Trap," I rated the stock as a sell and cautioned readers of As you can tell, our core style is to provide actionable and unambiguous ideas from our independent research. If your share this investment style, check out Envision Early Retirement. It provides at least 1x in-depth articles per week on such ideas.We have helped our members not only to beat S&P 500 but also avoid heavy ...

SAN DIEGO, Feb. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Walgreens Boots Alliance, Inc. (NASDAQ: WBA) common stock between April 2, 2020 and January 16, 2025, inclusive (the "Class Period"), have until March 31, 2025 to seek appointment as lead plaintiff of the Walgreens class action lawsuit. Captioned Klein v. Walgreens Boots Alliance, Inc., No. 25-cv-01058 (N.D. Ill.), the Walgreens class action lawsuit charges Walgreens as well as ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Walgreens Boots Alliance, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from April 2, 2020, to January 16, 2025 [1] Allegations - The complaint alleges that Walgreens violated federal laws related to the dispensation of prescription medication and reimbursement, despite claiming a commitment to regulatory compliance [1] - It is claimed that the company's conduct would lead to increased regulatory scrutiny, civil liability, and reputational damage [1] - The revenues from prescription medication sales are said to be unsustainable due to their reliance on unlawful practices [1] - As a result, Walgreens' public statements during the class period are characterized as materially false and misleading [1] Next Steps for Shareholders - Shareholders who purchased WBA shares during the specified timeframe are encouraged to register for the class action by March 31, 2025, to potentially become lead plaintiffs [2] - Registered shareholders will receive updates through a portfolio monitoring software throughout the case lifecycle [2] About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit, fraud, and illegal business practices [3] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [3]